首页 | 本学科首页   官方微博 | 高级检索  
     

木蹄复方提取物体内抗肿瘤作用研究
引用本文:何晓义,葛卫红,刘琼,沈先荣,何颖,蒋定文,陈伟,莫琳芳,刘玉明,侯登勇,王庆蓉,钱甜甜. 木蹄复方提取物体内抗肿瘤作用研究[J]. 中国实验方剂学杂志, 2013, 19(15): 170-173
作者姓名:何晓义  葛卫红  刘琼  沈先荣  何颖  蒋定文  陈伟  莫琳芳  刘玉明  侯登勇  王庆蓉  钱甜甜
作者单位:1. 浙江中医药大学中药体外代谢实验室,杭州,310053
2. 海军医学研究所防护医学研究室,上海,200433
基金项目:全军医学科技"十二五"重大项目(AS11J003)
摘    要:目的:考察木蹄复方提取物(ECF)的体内抗肿瘤活性,并探讨部分作用机制.方法:制备S 180和Lewis肺癌实体瘤小鼠模型,接种次日将2种实体瘤模型小鼠均分为模型组,EFC低、中、高剂量(0.05,0.1,0.15 g·kg-1)组和环磷酰胺(CTX)阳性对照组,分别连续给药8和15 d,观察ECF对荷瘤小鼠瘤质量、胸腺指数和脾脏指数、血清中肿瘤坏死因子-α(TNF-α)和巨噬细胞集落刺激因子(M-CSF)水平的影响.结果:ECF低、中、高3个剂量组对S 180荷瘤小鼠肿瘤抑制率分别为11.8%,47.1%和58.8%;对Lewis肺癌实体瘤小鼠肿瘤抑制率分别为7.1%,57.1%和28.6%.与模型组比较,ECF高剂量组能抑制S180荷瘤小鼠肿瘤的生长(P<0.05),提高胸腺指数(P<0.05),降低血清中M-CSF水平;中剂量组可抑制Lewis 肺癌荷瘤小鼠肿瘤的生长(P<0.05),提高胸腺指数(P<0.05),降低血清中M-CSF水平,3个剂量组均能提高血清中TNF-α水平(P <0.05,P<0.01).结论:ECF对S 180荷瘤小鼠和Lewis肺癌荷瘤小鼠肿瘤的生长具有明显抑制作用,显示较强的体内抗肿瘤活性,其作用机制可能与提高免疫器官指数以及调节血清中TNF-α和M-CSF的表达有关.

关 键 词:木蹄复方  体内  抗肿瘤  肿瘤坏死因子-a  巨噬细胞集落刺激因子
收稿时间:2013-01-04

Antitumor Effect of Extracts from Compound Fomes fomentarius in vivo
HE Xiao-yi,GE Wei-hong,LIU Qiong,SHEN Xian-rong,HE Ying,JIANG Ding-wen,CHEN Wei,MO Lin-fang,LIU Yu-ming,HOU Deng-yong,WANG Qing-rong and QIAN Tian-tian. Antitumor Effect of Extracts from Compound Fomes fomentarius in vivo[J]. China Journal of Experimental Traditional Medical Formulae, 2013, 19(15): 170-173
Authors:HE Xiao-yi  GE Wei-hong  LIU Qiong  SHEN Xian-rong  HE Ying  JIANG Ding-wen  CHEN Wei  MO Lin-fang  LIU Yu-ming  HOU Deng-yong  WANG Qing-rong  QIAN Tian-tian
Affiliation:Metabolism Laboratory of Traditional Chinese Medicine(TCM), Zhejiang Chinese Medicine University, Hangzhou 310053, China;Metabolism Laboratory of Traditional Chinese Medicine(TCM), Zhejiang Chinese Medicine University, Hangzhou 310053, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China;Department of Radiation Protection Medicine, Navy Medical Research Institute, Shanghai 200433, China
Abstract:
Keywords:compound Fomes fomentarius  in vivo  antitumor  TNF-α  M-CSF
本文献已被 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号